NCT05890508 Electro-acupuncture for Long Covid Neuropsychiatric Symptoms
| NCT ID | NCT05890508 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hong Kong Baptist University |
| Condition | Long Covid19 |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2026-01-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
In this study, a 16-week randomized, sham-controlled, double-blinded clinical trial will be conducted to to investigate the efficacy and safety of electro-acupuncture compared to sham acupuncture for treatment of long covid neuropsychiatric symptoms.
Eligibility Criteria
Inclusion Criteria: * adults over 18 years of age to 80; * history of SARS-CoV-2 PCR+ at least 4 weeks prior to study entry; SARS-CoV-2 negative (PCR) at study entry; * at least one persistent neurological symptom (impaired concentration, headache, sensory disturbances, or depression, or "brain fog") that began around the time of the acute COVID-19; * willing and able to consent, complete all assessment and study procedures. Exclusion Criteria: * any chronic or remote neurological disorder (i.e. stroke, head trauma, epilepsy, tumor); * intellectual disability pre-existing to the Covid-19 episode;cardiovascular diseases such as arrhythmia, heart failure, myocardial infarction, and patients with cardiac pacemakers, * acute brain injury or acute encephalopathy from another aetiology than covid (e.g., sepsis, liver or renal failure, alcohol or drug withdrawal, drug toxicity); * documented pre-existing history of psychiatric illness, including substance abuse; * open-heart cardiac surgery o
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.